Related Experiment Video
Updated: Aug 8, 2026
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
An improved clonal excess assay using flow cytometry and B-cell gating
B W Letwin1, P K Wallace, K A Muirhead
1Smith Kline & French Labs, King of Prussia, PA.
Insights
A new two-color immunofluorescence assay improves detection of B-cell malignancies. This method accurately identifies low levels of monoclonal B lymphocytes (clonal proliferation) in patient samples.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Detecting monoclonal B lymphocytes is crucial for diagnosing B-cell malignancies.
- Existing single-color immunofluorescence assays have limitations in sensitivity and specificity due to background noise and low B-cell counts.
- These limitations hinder the accurate detection of low levels of clonal excess, particularly in minimal disease states.
Purpose of the Study:
- To develop an improved immunofluorescence assay for sensitive and specific detection of monoclonal B lymphocytes.
- To overcome the limitations of previous single-color techniques in identifying low levels of clonal excess.
- To enhance the diagnostic accuracy for B-cell malignancies.
Main Methods:
- Utilized two-color immunofluorescence staining with anti-kappa and anti-lambda reagents.
- Implemented B-cell gating to specifically analyze B lymphocytes and exclude non-B cells.
- Avoided restrictive light scatter gates to maintain sensitivity for true positive cases.
Main Results:
- The developed assay demonstrates high sensitivity, detecting as low as 0.2% monoclonal B cells in fresh samples.
- Sensitivity remains robust for stored samples (0.6% monoclonal B cells after 72 hours).
- The assay readily detects 1% monoclonal cells in patient specimens, offering improved specificity over single-color methods.
Conclusions:
- The two-color, B-cell gated immunofluorescence assay provides enhanced specificity for detecting low levels of clonal excess.
- This improved method offers sensitivity comparable to single-color assays but with significantly reduced false positives.
- The assay is a valuable tool for the accurate diagnosis and monitoring of B-cell malignancies.
Abstract:
In humans with B-cell malignancies, the presence of monoclonal B lymphocytes (clonal proliferation) can be detected by comparing the fluorescence intensity distributions of lymphocytes stained with anti-kappa and anti-lambda reagents. The sensitivity of previously described single-color immunofluorescence techniques to low levels of clonal excess is limited by background from cytophilic immunoglobulins on non-B cells and by the low proportion of circulating B cells in individuals with minimal disease. We have used two-color immunofluorescence and B-cell gating to develop an improved assay that avoids false positives due to non-B cells, without requiring restrictive light scatter gates that may exclude true positives. This method is sensitive to 0.2% monoclonal B cells admixed with fresh normal lymphocytes, to 0.6% monoclonal B cells admixed with normal lymphocytes that have been stored for up to 72 hours, and readily detects 1% monoclonal cells in patient specimens. The two color B-cell gated assay offers sensitivity equivalent to the single-color assay and improved specificity for detection of low levels of clonal excess.
